Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
40 studies found for:    Islets of Langerhans Transplantation | Open Studies
Show Display Options
Rank Status Study
21 Not yet recruiting Complement Inhibitor Eculizumab in Clinical Islet Transplantation
Condition: Diabetes Mellitus
Intervention: Drug: Eculizumab
22 Unknown  Cotransplantation of Islet and Mesenchymal Stem Cell in Type 1 Diabetic Patients
Condition: Type 1 Diabetes Mellitus
Intervention: Biological: cotransplantation of islet and mesenchymal stem cell
23 Recruiting Minimal Islet Transplant at Diabetes Onset
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Human pancreatic islet;   Drug: ATG;   Drug: Pegylated G-CSF;   Drug: Rapamycin
24 Recruiting Extending Indication for Islet Autotransplantation in Pancreatic Surgery
Condition: Diabetes
Intervention:
25 Recruiting Carbon Monoxide-Saturated Medium for Islet Isolation
Condition: Chronic Pancreatitis
Intervention: Other: Carbon monoxide-bubbled mediums
26 Recruiting Omental Islet Transplant
Condition: Type 1 Diabetes
Interventions: Procedure: Omental Islet transplant;   Drug: Anti-Thymocyte Globulin;   Drug: Mycophenolate mofetil;   Drug: Tacrolimus;   Drug: Etanercept;   Drug: Sirolimus
27 Recruiting Metabolic Efficiency of Combined Pancreatic Islet and Lung Transplant for the Treatment of End-Stage Cystic Fibrosis
Conditions: Cystic Fibrosis;   Diabetes Related Cystic Fibrosis
Intervention: Procedure: Combined pancreatic islet and lung transplantation
28 Unknown  MRI Imaging of Labeled Human Islets Transplanted Into the Liver
Condition: Type 1 Diabetes Mellitus
Intervention: Other: Transplantation of labeled islets
29 Recruiting Mesenchymal Stem Cell and Islet Co-transplantation
Conditions: Chronic Pancreatitis;   Diabetes
Intervention: Biological: autologous mesenchymal stromal cell
30 Not yet recruiting Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant
Conditions: Kidney Transplant;   Type 1 Diabetes
Interventions: Drug: Alpha 1-Antitrypsin;   Procedure: Islet Transplantation;   Drug: Thymoglobulin;   Drug: Basiliximab;   Drug: Etanercept
31 Recruiting Evaluation of the Efficacy of Intramuscular Islet Autograft After Extensive Pancreatectomy
Condition: Disorder of Endocrine Pancreas
Intervention: Drug: Intramuscular Islet Autograft
32 Not yet recruiting Assessment of Insulin Sensitivity and β Cell Function by Clamps Studies
Condition: Diabetes Mellitus, Non-Insulin-Dependent
Intervention: Biological: MNCs
33 Recruiting Long Term Follow up of Recipients of Functional Islet Allografts
Condition: Type 1 Diabetes Mellitus
Intervention:
34 Recruiting New Imaging Procedure for the Localisation of Insulinoma and Transplanted Islet Cells
Conditions: Endogenous Hyperinsulinaemic Hypoglycaemia;   Transplanted Islet Cells
Intervention: Other: Ga -exendin PET/CT, In- exendin SPECT/CT, MRI
35 Recruiting Islet Autotransplantation in Patients at Very High-risk Pancreatic Anastomosis
Condition: Postpancreatectomy Hyperglycemia
Interventions: Procedure: Pancreaticoduodenectomy with pancreatic anastomosis;   Procedure: Total pancreatectomy with islet autotransplantation
36 Recruiting Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss
Condition: Type 1 Diabetes Mellitus
Intervention:
37 Recruiting Bet Cell Therapy in Diabetes Type 1
Condition: Type 1 Diabetes
Intervention: Other: Transplantation of encapsulated beta cells.
38 Unknown  Long-term Function of Beta Cell Allografts in Non-uremic Type 1 Diabetic Patients
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: ATG-MMF-TAC;   Drug: ATG-Rituximab-MMF-TAC;   Drug: ATG-basilixumab-MMF-TAC;   Procedure: omentum
39 Recruiting Efficacy and Safety of Reparixin in Pancreatic Islet Auto-transplantation
Condition: Pancreatectomy for Chronic Pancreatitis
Interventions: Drug: Reparixin;   Drug: Placebo
40 Available Islet Transplant for Type 1 or Surgical Diabetes
Conditions: Type 1 Diabetes Mellitus;   Hypoglycemia;   Labile Diabetes;   End-stage Renal Disease
Intervention: Biological: Allogeneic islets of Langerhans

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page   
Indicates status has not been verified in more than two years